Prostate Cancer
Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells - implications for systemic control.
January 8, 2024
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
January 5, 2024
Approach to Patients with High-Risk Localized Prostate Cancer: Radiation Oncology Perspective.
January 5, 2024
PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
January 5, 2024